全球肺功能倡议肺量计参考方程在东北亚慢阻肺患者中的应用影响
本研究基于韩国慢阻肺亚组研究(KOCOSS)3,477例患者的系列肺量计数据,重新比较2012 GLI种族特异方程、2022 GLI种族中立方程与韩国Choi方程的判读效果。结果显示三种方程对慢阻肺诊断一致性高,但GLI方程使部分患者被重分类为更轻 severity;各方程计算的FEV1占预计值百分比与呼吸困难、运动能力、生活质量及急性加重频率的关联均持续显著。
要点
- GLI方程与Choi方程对慢阻肺诊断一致性高,但可导致疾病严重度分级向轻症偏移。
- 2012 GLI与2022 GLI方程分别使17.0%和23.4%的患者被重分类为更轻的疾病严重度。
- 各方程计算的FEV1占预计值百分比与关键临床结局的显著关联保持一致。
核心结论
- 在东北亚慢阻肺患者中应用GLI参考方程可能影响疾病严重度分级,进而影响临床管理与临床试验入组。
- GLI方程判读下FEV1占预计值百分比与关键疾病结局的显著关联仍保持一致。
研究设计与样本
- 基于韩国慢阻肺亚组研究(KOCOSS)3,477例患者的系列肺量计数据进行再分析。
- 比较2012 GLI种族特异方程、2022 GLI种族中立方程与Choi参考方程的判读结果。
主要发现
- 三种方程对慢阻肺诊断一致性高,但2012 GLI和2022 GLI方程分别使17.0%和23.4%的患者被重分类为更轻的疾病严重度。
- 各方程计算的FEV1占预计值百分比与呼吸困难严重度、运动能力、健康相关生活质量和急性加重频率的关联均持续显著。
- 各方程下FEV1与FVC占预计值的年下降率相似,但Choi方程下FEV1年下降率较2022 GLI种族中立方程更慢。
临床怎么用
- 呼吸科医生判读慢阻肺患者肺量计时需注意GLI方程可能使严重度分级偏轻,影响治疗决策与试验入组。
- 换用GLI方程后应结合症状、运动能力和急性加重等临床结局综合评估,而非仅依赖严重度分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate spirometry interpretation is critical in the diagnosis and management of COPD. With increasing efforts for a unified approach by the Global Lung Function Initiative (GLI), this study evaluated the application of race-specific 2012 GLI and race-neutral 2022 GLI reference equations compared with Choi's reference equations, which are derived and widely used in South Korea, for spirometry interpretation in Northeast Asian patients with COPD. RESEARCH QUESTION: What are the effects of applying race-specific 2012 GLI, race-neutral 2022 GLI, and Choi's reference equations on the diagnosis, severity grade, and clinical outcome associations of COPD? STUDY DESIGN AND METHODS: Serial spirometry data from the Korea COPD Subgroup Study (KOCOSS) consisting of 3,477 patients were used for reanalysis using 2012 GLI, 2022 GLI, and Choi's reference equations. The COPD diagnosis and severity categorization, associations with disease manifestations and health outcomes, and longitudinal trajectories of lung function were determined. RESULTS: Although there was strong concordance in COPD diagnosis comparing 2012 GLI, and 2022 GLI reference equations with Choi's reference equations, a notable portion of patients were reclassified to milder disease severity (17.0% and 23.4% for 2012 GLI and 2022 GLI reference equations, respectively). Relationships between FEV1 % predicted values calculated using 2012 GLI, 2022 GLI, and Choi's equations with clinical outcomes including dyspnea severity, exercise capacity, health-related quality of life, and frequency of exacerbations remain consistently significant. Similar annual decline rates of FEV1 and FVC % predicted were observed among the reference equations used, except for slower annual decline rate of FEV1 in Choi's equation compared with 2022 GLI race-neutral equation. INTERPRETATION: Application of GLI reference equations for spirometry interpretation in Northeast Asian patients with COPD has potential implications on disease severity grade for clinical management and trial participation, and maintains consistent significant relationships with key disease outcomes.
引用
- Choi JY, Lee CH, Joo H, et al. Implications of Global Lung Function Initiative Spirometry Reference Equations in Northeast Asian Patients With COPD. Chest. 2024. PMID: 39276977. doi:10.1016/j.chest.2024.08.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。